Abbott Drug Abuse Test Group - Negative Correction Solution Group - Taiwan Registration 56b0925bcc85b5f311c1d38e96de6ef0
Access comprehensive regulatory information for Abbott Drug Abuse Test Group - Negative Correction Solution Group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 56b0925bcc85b5f311c1d38e96de6ef0 and manufactured by MICROGENICS CORPORATION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used on the Alinity c analyzer to correct the detection of amphetamine/methamphetamine, barbiturates, cannabinoids, cocaine metabolites, ecstasy, methadone, Opiates, phencyclidine and propoxyphene drug of abuse (DOA) analysis.
A Clinical chemistry and clinical toxicology
A.1150 Calibrated Products
Input;; QMS/QSD
Dates and Status
Sep 25, 2020
Sep 25, 2025

